Navigation Links
Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting
Date:5/14/2009

ltimate goal of helping to improve the lives of patients."

Nexavar's Differentiated Mechanism

Nexavar targets both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to target members of two classes of kinases known to be involved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is currently approved in more than 70 countries for the treatment of patients with liver cancer and in more than 80 countries for the treatment of patients with advanced kidney cancer. Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators as a single agent or combination treatment in a wide range of cancers, including breast cancer, colorectal cancer, lung cancer, ovarian cancer, and as an adjuvant therapy for kidney cancer and liver cancer.

Important Safety Considerations For Patients Taking Nexavar

Based on the currently approved U.S. package insert for the treatment of patients with unresectable hepatocellular carcinoma and advanced kidney cancer, hypertension may occur early in the course of therapy and blood pressure should be monitored weekly during the first six weeks of therapy and treated as needed. In HCC patients, bleeding with a fatal outcome from any site was reported in 2.4% for Nexavar and 4% in placebo. The incidence of treatment-emergent cardiac ischemia/infarction was 2.7% for Nexavar vs. 1.3% for placebo. In RCC patients, incidence of bleeding regardless of causality was 15% for Nexavar vs. 8% for placebo and the incidence of treatment-emergent cardiac ischemia/infarction was 2.9% for Nexavar vs. 0.4% for placebo. Most common adverse events 20% related to Nexavar for both HCC and RCC were fatigue, weight loss, ra
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability
2. Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
3. Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG
4. GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years
5. Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants
6. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
7. CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
8. Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
9. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
10. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
11. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Array BioPharma Inc. (NASDAQ: ... reached a definitive agreement with Novartis Pharma AG to ... currently in Phase 3 development.  This agreement is conditional on ... PLC (GSK) on April 22, 2014, which are expected to ...
(Date:1/22/2015)... COLUMBIA, Md. (PRWEB) January 22, 2015 ... of its new UV-1280 multipurpose UV-visible spectrophotometer. Offering ... compact, high-quality instrument is ideal for applications in ... and life science. , The user-friendly UV-1280 enables ...
(Date:1/22/2015)... 22, 2015  Transwestern | RBJ today announces the firm brokered ... for Shire a leading biopharmaceutical company, at Two Ledgemont Center ... Robert Richards , president, and Brian Cohen , ... entire five-floor building at 95 Hayden Ave. Photo ...
(Date:1/22/2015)... January 22, 2015 Protocol Networks brings ... growing team of brand-neutral, independent consultants, Protocol Networks has ... explained that over the years, his company has attracted ... Town of Plainfield, as well as others. With the ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2
... Childhood Cancer Research Organization Looks to CMM for,Professional ... Treatment, GRAND RAPIDS, Mich., Jan. 8 ... has been selected by the Children,s,Oncology Group (COG) ... of a study to evaluate the existence of ...
... Jan. 8 Substantial progress and,momentum behind its research-and-development ... deliver several new blockbuster products to farmers,by 2012, company ... part of a series of presentations on the company,s ... to see such innovation in the pipeline right now," ...
... of leading treatment planning software developer would, strengthen Elekta,s ... ... STOCKHOLM, Sweden, Jan. 8 Elekta AB (publ) (STO: ... today announced that it is in exclusive negotiations based on,a ...
Cached Biology Technology:Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study 2Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study 3Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study 4Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 2Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 3Elekta Negotiates To Acquire CMS 2Elekta Negotiates To Acquire CMS 3Elekta Negotiates To Acquire CMS 4Elekta Negotiates To Acquire CMS 5
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... the Three Musketeers who lived by the motto "All ... do their own thing. For years, debate swirled around ... a central growth regulatory module. Now, the cooperation model ... Biological Studies. They show that each hormone acts largely ...
... suspected, fast help is required. The first step is ... simple, identification of the pathogen; preferably, this test should ... laboratory. Portable miniature biodetection systems that can detect multiple ... American researchers from Lawrence Livermore National Laboratory led by ...
... microscope so powerful that it allows scientists peering ... nearly each individual protein they are studying has ... the Howard Hughes Medical Institute's Janelia Farm Research ... Institutes of Health and Florida State University. , ...
Cached Biology News:Computational analysis shows that plant hormones often go it alone 2Computational analysis shows that plant hormones often go it alone 3Encoded metallic nanowires reveal bioweapons 2New light microscope sharpens scientists' focus 2New light microscope sharpens scientists' focus 3New light microscope sharpens scientists' focus 4New light microscope sharpens scientists' focus 5New light microscope sharpens scientists' focus 6
... DNA isolation. Designed to hold ... well plate adapters from Mo Bio). ... plate length (max capacity is 192 ... for soil, microorganisms, animal tissue, plants, ...
... Chicken polyclonal to LYZL6 ( Abpromise ... Antigen: Synthetic peptide: ... HVDCQD , corresponding to amino acids ... Entrez Gene ID: 57151 ...
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
Request Info...
Biology Products: